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Abstract: Although the application of cardioprotective ischaemia/reperfusion (I/R) stimuli after
myocardial infarction (MI) is a promising concept for salvaging the myocardium, translation to
a clinical scenario has not fulfilled expectations. We have previously shown that in pigs, ischaemic
postconditioning (IPostC) reduces myocardial oedema and microvascular obstruction (MVO), without
influencing myocardial infarct size. In the present study, we analyzed the mechanisms underlying the
IPostC-induced microvascular protection by transcriptomic analysis, followed by pathway analysis.
Closed-chest reperfused MI was induced by 90 min percutaneous balloon occlusion of the left anterior
descending coronary artery, followed by balloon deflation in anaesthetised pigs. Animals were
randomised to IPostC (n = 8), MI (non-conditioned, n = 8), or Control (sham-operated, n = 4) groups.
After three hours or three days follow-up, myocardial tissue samples were harvested and subjected to
RNA-seq analysis. Although the transcriptome analysis revealed similar expression between IPostC
and MI in transcripts involved in cardioprotective pathways, we identified gene expression changes
responding to IPostC at the three days follow-up. Focal adhesion signaling, downregulated genes
participating in cardiomyopathy and activation of blood cells may have critical consequences for
microvascular protection. Specific analyses of the gene subsets enriched in the endothelium of the
infarcted area, revealed strong deregulation of transcriptional functional clusters, DNA processing,
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replication and repair, cell proliferation, and focal adhesion, suggesting sustentative function in the
endothelial cell layer protection and integrity. The spatial and time-dependent transcriptome analysis
of porcine myocardium supports a protective effect of IPostC on coronary microvasculature post-MI.
Keywords: ischemia-reperfusion injury; acute myocardial infarction; ischemic postconditioning;
transcriptome; porcine model
1. Introduction
Since the first demonstration of cardioprotection in a postconditioned cat model, decades of
intensive research have been devoted to the translation of ischaemic postconditioning (IPostC) to
clinical settings [1]. Preclinical research on rodents argues in favor of IPostC-elicited cardioprotection
manifesting improved outcomes of myocardial infarction (MI) [2,3]. However, large animal models
of IPostC have demonstrated varying success with regards to improvement in left ventricular
function and reduced infarct size [4,5]. Recent clinical studies have reported heterogeneous outcomes
when applying IPostC immediately after achieving reperfusion in primary percutaneous coronary
intervention for ST-segment elevation myocardial infarction (STEMI) [6–8]. The recent DANAMI-3
IPost and POST trials failed to show any benefit of postconditioning for patients in regards to all-cause
death and heart failure [6,9]. The discrepancies between preclinical models showing beneficial effects,
and clinical trials failing to show meaningful cardioprotection, have been attributed to differences in
study design, the assessment of cardioprotective effects (imaging or biochemical markers vs. clinical
outcome), and heterogeneous study populations in clinical trials with an impact of co-morbidities and
co-medications, particularly anaesthetics [10].
We have previously shown that performing six 30 s cycles of ischaemia/reperfusion (I/R) stimuli
applied immediately after a prolonged ischaemic insult in a clinically relevant porcine model of
reperfused MI, fails to attenuate the size of myocardial necrosis assessed by cardiac magnetic resonance
imaging (MRI). However, IPostC conferred cardioprotection on the coronary microvasculature
and significantly reduced myocardial oedema and microvascular obstruction (MVO), which were
quantified by late gadolinium-enhanced cardiac MRI [11]. MVO is a no-reflow phenomenon after
reperfusion therapy in acute MI, and a major contributor to the reperfusion injury. MVO is characterized
as a prolonged perfusion defect caused by endothelial cell swelling and protrusion, with accumulation
of platelets, and neutrophils resulting in capillary obstruction. It is recognized as a serious complication
for coronary flow restoration, and a poor prognostic marker of infarct expansion and left ventricular
remodeling [12]. The occurrence and extent of the MVO on late enhancement gadolinium MRI images
detected 3–5 days after primary percutaneous coronary intervention in patients with STEMI has
recently been shown to be a strong predictor of long-term cardiovascular adverse events [13].
As shown in detail previously, MVO was detected and quantified three days post MI
using cardiac MRI [11]. Briefly, the hypointense zone in the center of hyperenhancement in late
gadolinium-enhanced MRI images was quantified, and values were expressed relative to the left
ventricular mass. IPostC significantly decreased the MVO volume compared to myocardial infarction
without cardioprotection [11].
Therefore, the aim of the present study was to identify molecular targets and mechanisms that
explain the microvasculature protection elicited by IPostC. We performed transcriptomic analyses
on myocardial samples isolated from pigs that underwent MI followed by IPostC. The results
were compared to the transcriptomic changes in animals after non-conditioned MI, as unbiased
RNA-sequencing enables the identification of novel targets [10,14,15]. Our previous analysis of gene
expression patterns in the infarcted and remote (non-ischaemic) areas in pigs that had underwent
repetitive I/R stimuli without infarction, revealed the capacity of preconditioning cycles to induce
intrinsic remote conditioning of the myocardial regions unaffected by ischaemia, suggesting the
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prevention of adverse ventricular remodeling [16]. Conditioning-induced myocardial salvage is
a bi-phasic action; we therefore evaluated the transcriptomic profile of the infarct-related and remote
tissues at three hours and three days after MI and IPostC.
To the best of our knowledge, this is the first study to evaluate the effect of IPostC on microvascular
protection at the molecular level, at different time windows, in a translational large animal model
of MI.
2. Results
2.1. Assessment of Infarct Severity
Detailed data, including cardiac function and assessment of MVO for these experimental groups
were published previously [11].
Briefly, IPostC failed to reduce the area at risk as assessed by cardiac imaging and necrosis in
triphenyl tetrazolium chloride (TTC) histological staining, but reduced the extent of both myocardial
oedema and MVO. Analysis of circulating biochemical markers demonstrated an effect of MI and
IPostC on the enzymatic release of myoglobin, an early marker of myocardial damage, and cardiac
troponin I type 3 (cTnI3), an indicator of acute myocardial injury with typical release within hours up
to a few days after MI.
MI with (p = 0.0243) and without (p = 0.0016) IPostC induced a significant release of myoglobin
into the plasma compared to the control group at the 3-h follow-up, and increased serum cTnI3
concentrations at the 3-day follow-up (without IPostC, p = 0.0004; with IPostC, p = 0.0061; Figure 1B),
without any differences among groups.
2.2. Circulating Cardioprotective Markers
Figure 1C demonstrates the release of potentially cardioprotective circulating proteins following
MI and IPostC. SDF-1α and IL-8 plasma concentrations in the MI-3h, MI-3d, IPostC-3h, and IPostC-3d
groups remained unchanged compared to the control group. The release of CXCR4 into plasma was
significantly increased compared to controls only in the MI-3d group (p = 0.0048). MI and IPostC
induced a parallel significant increase in MMP-2 in the plasma at three hours (MI-3h: p = 0.007;
IPostC-3h: p = 0.011) and three days (MI-3d: p = 0.0004; IPostC-3d: p = 0.0003) post-infarction
compared to the control group. FGF plasma concentrations were significantly elevated only in the
MI-3h (p = 0.0409) and MI-3d (p = 0.0384) groups. In contrast, a significant increase in VEGF was
observed at 3d in the IPostC (p = 0.0384) group.
2.3. Analysis of Next Generation Sequencing Expression Data
All sequenced genes were subjected to principal component analysis (PCA) to identify clustering,
revealing a distinct difference between sham-operated control and treatment groups. However,
considerable variation in the population structure was found between the IPostC and MI groups
(Supplementary Figure S1).
In order to assess the transcriptional response in individual cell types present within the
myocardial tissue, we used bioinformatic analysis to classify gene transcripts according to their
documented specific enrichment in cardiac muscle cells, endothelial cells, and fibroblasts (Figure 2A–C).
Comparison across treatment groups showed that considerable changes in gene expression were
evident, particularly at the later time point in the remote area of both the MI and IPostC groups.
In the infarcted area at three days, a higher number of transcripts were dysregulated in all cell types,
including the endothelium, and a substantial transcriptomic response to MI, with or without IPostC,
was observed in the remote area of the IPostC-3d and MI-3d groups (Supplementary Figures S2 and S3).
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Figure 1. Study design for the porcine closed-chest reperfused model of myocardial infarction and 
ELISA results. Pigs underwent 90-min occlusion of the mid-left anterior descending coronary artery 
(LAD), followed by reperfusion. Postconditioning stimuli were induced at the onset of the reperfusion 
phase by six 30 s cycles of ischaemia/reperfusion. (A) Infarct severity was assessed by myoglobin 
plasma concentration and cardiac troponin I 3 serum concentrations. (B) Circulating cardioprotective 
markers in the Control (n = 4), MI-3h (n = 4), MI-3d (n = 4), IPostC-3h (n = 4), and IPostC-3d (n = 4) 
groups. (C) * p < 0.05; and ** p < 0.01 (one-way ANOVA/Tukey post-hoc).  
Figure 1. Study design for the porcine closed-chest reperfused model of myocardial infarction and
ELISA results. Pigs underwent 90-min occlusion of the mid-left anterior descending coronary artery
(LAD), followed by reperfusion. Postconditioning stimuli were induced at the onset of the reperfusion
phase by six 30 s cycles of ischaemia/reperfusion. (A) Infarct severity was assessed by myoglobin
plasma concentration and cardiac troponin I 3 serum concentrations. (B) Circulating cardioprotective
markers in the Control (n = 4), MI-3h (n = 4), MI-3d (n = 4), IPostC-3h (n = 4), and IPostC-3d (n = 4)
groups. (C) * p < 0.05; and ** p < 0.01 (one-way ANOVA/Tukey post-hoc).
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Differentially expressed genes (DEGs) were clustered according to their involvement in molecular
pathways and networks by performing Signalling Pathway Impact Analysis (SPIA) with Kyoto
Encyclopedia of Genes and Genomes (KEGG) data. We found largely analogous enrichment of calcium
signaling and smooth muscle cell contraction in both MI and IPostC groups in the first window,
and an inhibition of apoptosis-associated genes in the MI group but not IPostC group (Supplementary
Table S2).
Three days post intervention, a more complex transcriptomic response (Supplementary Table S3)
was detected with activation of immune responses and upregulation of transcripts involved in cell
stress. Interestingly, the infarcted area was more strongly influenced in the IPostC group, whereas the
remote myocardium was impacted in the MI group.
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2.4. Effect of IPostC on Pro-Survival Pathways
We directly compared IPostC and MI to discern cardioprotective mechanisms induced by IPostC
from the more general transcriptional response induced by ischaemia and reperfusion. Figure 3 and
supplementary Table S4 show the log2 fold changes in genes relative to the control group that are
involved in cardioprotective pathways.
We found a generally similar response between the MI and IPostC groups in the remote and
infarcted zones of both time windows. However, some genes exhibited distinct regulation by IPostC.
The expression of several receptors (EGFR, ADORA3, and INSR) was significantly elevated in both
the MI and IPostC groups. Kinases responsible for signal transduction exhibited a similar expression
pattern in the MI and IPostC groups.
The negative mTOR regulator, DEPTOR, was significantly overexpressed in all groups at
three days, together with inhibition of mTOR effectors. An evident activation of JAK/STAT signaling,
based on the expression of major pathway components, was not confirmed in the pigs, and the
expression of transcriptional regulators associated with JAK/STAT was ambiguous. However,
many genes involved in reactive oxygen species (ROS) metabolism and genes encoding antioxidants
were downregulated, and exhibited similar regulation across all sample groups in the AMI and
IPostC groups.
2.5. Analysis of Genes with Opposite Regulation in MI and IPostC
A total of 15 transcripts exhibited opposite regulation between the MI and IPostC groups at the
three hour follow-up (Figure 4A), suggesting that IPostC causes only minor transcriptional changes
in the early window. In contrast, the second window revealed more than 150 genes with significant
opposite regulation. Clustering based on pathway enrichment (Figure 4B) indicated downregulation of
genes responsible for extracellular matrix (ECM) degradation (MMP14, and MMP9), and upregulation
of the focal adhesion pathway (ZYX, CAVs, and LAMB). The remote area inhibited transcription of
ribosomal proteins in the IPostC group, but not the MI group, suggesting increased protein synthesis
after MI that was attenuated by IPostC. Similarly, gene sets participating in the formation and transport
of cellular vesicles (VPS, DNM, KDELR, and SCAMPs) were significantly downregulated in the remote
area of the IPostC group, but induced in the MI group.
In addition, we observed downregulation of transcripts involved in the activation of platelets and
leukocytes (SERPINE, SELE, VCAM1, ICAM2, L1CAM, and CCLs) in the remote area of the IPostC
group compared to the MI group. Similar gene expression patterns were observed in the cluster of
cardiomyopathy genes (GNAs, MTHFR, CREBs, and FASN).
Taken together, the results suggest that IPostC triggers a downregulation of ECM-proteinases,
ribosomal subunits, platelet and leukocyte adhesion, and vesicular transport proteins, and it also
induces focal adhesions. In addition, IPostC inhibits the activation of inflammatory leukocytes and
cardiac hypertrophy on the expression level.
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Figure 3. Heat maps of selected differentially expressed genes (DEGs) involved in cardioprotection, 
showing regional and time-dependent changes in expression changes. DEGs in the MI-3h (n = 3), MI-
3d (n = 3), IPostC-3h (n = 3), and IPostC-3d (n = 3) groups are related to the control group (n = 3). 
Colors indicate the extent of log2 fold decrease (green) or increase (red) (p-value < 0.05, moderated t-
statistics adjusted for multiple testing). Grey indicates non-significant regulation. 
Figure 3. Heat maps of selected differentially expressed genes (DEGs) involved in cardioprotection,
showing regional and time-dependent changes in expression changes. DEGs in the MI-3h (n = 3),
MI-3d (n = 3), IPostC-3h (n = 3), and IPostC-3d (n = 3) groups are related to the control group (n = 3).
Colors indicate the extent of log2 fold decrease (green) or increase (red) (p-value < 0.05, moderated
t-statistics adjusted for multiple testing). Grey indicates non-significant regulation.
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protection against myocardial oedema and MVO [11]. A detailed analysis showed that subunits of 
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Figure 4. Heat maps of differentially expressed genes (DEGs) with opposite regulation in the
yocardial infarction ( I) (A), and ischaemic postconditioning (IPostC) groups (B). DEGs in the
MI-3h (n = 3), MI-3d (n = 3), IPostC-3h (n = 3), and IPostC-3d (n = 3) groups are related to the control
group (n = 3). Colors indicate the extent of log2 fold decrease (green) or increase (red) (p-value < 0.05,
oderated t-statistics adjusted for ultiple testing). rey indicates non-significant regulation.
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pregulation of the focal adhesion path ay is associated ith beneficial echanical and
functional changes in the cardiac tissue involving cell structure and volu e, resulting in the observed
protection against yocar ial oe e a an [11]. detaile analysis sho e that subunits of
integrin receptors (ITGB1, ITGB2, initiating focal adhesion signaling) were significantly upregulated in
the infarcted zone of the IPostC group.
verex ressio of cytoskeletal rotei s res o sible for t e reg latio of focal adhesio as
evi ent in both the re ote an infarcte zones of the I ost -3 gro . yrosine kinases involve in
the activation and transduction of focal adhesion signals were significantly upregulated.
e hypothesize that focal adhesio activatio a c a ges i cell str ct re affecte the
ex ression of ge es i volve i car iac scle y ertro y (car io yo athy) a t e reg latio of
cell volume (formation of oedema) (Figure 5A). We observed significant downregulatio of transcripts
involved in cardiomyopathy in the remote and infarcted zones of the IPostC group. Similarly,
the expression of oedema markers was downregulate or on-significantly regulated. Changes in the
expression of oedema markers in the MI groups were ambig ous (Figure 5B).
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cell adhesion and cytokine receptor signaling, such as DBF4, ITGA4, and LIMD1, and more specifically
in leukocyte adhesion (SELL, PTPRC) were upregulated in the infarcted area of the IPostC group,
suggesting sustentative function in the endothelial cell layer protection and integrity.
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2.7. qPCR Validation of Transcripts Involved in Focal Adhesion
After identifying individual DEGs involved in the focal adhesion pathway, we validated these
changes using qPCR analysis. Nor alized gene expression revealed analogous gene regulation by
IPostC co pared to I, confir ing RNA-seq data (Figure 7). Subunits of integrin receptors ITGB1
(p = 0.03) and ITGB2 (p = 0.01), were upregulated in the IPostC-3d group (Figure 7A,B). Protein
tyrosine-kinase 2-beta (PTK2B) was upregulated in the remote area of the IPostC group at both early
(p = 0.03) and late time points (p = 0.05; Figure 7C). The proto-oncogene non-receptor tyrosine kinase
SRC was not significantly regulated by IPostC (Figure 7D).
RNA expression of v-akt urine thy o a viral oncogene ho olog 1 (AKT) was significantly
increased in the remote area of the IPostC-3d group (p = 0.05; Figure 7E). Vinculin (VCL) expression was
significantly decreased in the infarcted area of the IPostC-3d group, and a trend towards a significant
increase was observed in the remote area of the IPostC-3d group (p = 0.06; Figure 7F).
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3. Discussion
To the best of our knowledge, this is the first description of myocardial whole-transcriptome
expression patterns after postconditioning stimuli in a translational experimental model,
demonstrating time-dependent changes of gene expression in remote and ischaemic regions.
The transcriptional profile of genes involved in cardioprotective pathways exhibited largely analogous
responses after MI and IPostC. However, we show a substantial transcriptional response to IPostC
after three days. IPostC induced differential regulation of transcripts coding for ECM proteinases,
genes involved in focal a hesion, cellular metabolism, and protein biosynthesis and processing.
Although IPostC cycles mediated certain changes, they were apparently insufficient for translation
into a clinically relevant cardioprotective effect. The obvious beneficial effect of IPostC in the pig
model is a protection of the cor nary microvasculature, reducing oedema and MVO [11]. In line with
these findings, we identified several olecular targets involved in microvascular protection i duced
by IPostC.
3.1. Large Animal Model of IPostC
Na et al. published the first study to introduce the concept of IPostC. They described prevention
of reperfusion-induced ventricular fibrillation by postconditioning stimuli in a cat model [1]. Although
the subsequent experimental studies in rodents [3], rabbits [17], and pigs [4] provided a substantial
amount of data, a clear and universal beneficial effect could not be confirmed due to the varying
outcomes in different experimental settings. In our study, we utilized a reperfused porcine AMI model
with 90 min coronary occlusion representing myocardial ischaemia, followed by reperfusion. This is
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the best available preclinical model to simulate human primary percutaneous coronary intervention
(PCI) [18]. Postconditioning cycles were applied immediately at the onset of reperfusion, as several
studies have demonstrated a diminished beneficial effect of IPostC when I/R cycles are applied in
the later phase of reperfusion [17,19]. We showed that six 30 s I/R stimuli applied immediately after
achieving reperfusion are ineffective for reducing enzymatically estimated infarct sizes at three hours
or three days. Similarly, left ventricular ejection fraction and myocardial necrosis were not affected by
IPostC [11], and the protective effect is limited to a reduction of microvascular oedema and MVO.
3.2. Release of Circulating Cardioprotective Cytokines
Salvaging affected myocardial tissue after MI is attributed to the secretion of cytokines and
inhibition of other pro-inflammatory stimuli. Preconditioning stimuli have been shown to enhance
the enzymatic release of chemotactic cytokines with parallel mobilization of hematopoietic stem
cells [20,21], which may have a protective effect against I/R injury at the myocyte level.
We observed a significant increase in MMP-2 and VEGF in response to MI, without an impact
of IPostC, confirming earlier reports [22]. Increased VEGF may contribute to cardiac microvascular
protection, but VEGF expression was not significantly induced in myocardial tissue samples by
IPostC compared to MI at the examined time points. The release of SDF-1, CXCR4, IL-8, and FGF
in the MI and IPostC groups exhibited a tendency towards an increase, but this did not reach
significance. The plasma VEGF concentration significantly increased three days after IPostC. Studies
demonstrating the benefits of preconditioning stimuli in pig [21] and rat [20] models detected the
release of cardioprotective cytokines within a few hours following the initiation of reperfusion.
Insufficient secretion of cardioprotective cytokines into the peripheral circulation may explain the
failure of IPostC to confer a protective benefit in this study.
3.3. Analogous Response of MI and IPostC to Prosurvival Pathways
Numerous studies have reported the activation of cellular prosurvival pathways in response to
postconditioning stimuli. PI3K/AKT [23], RISK [24], JAK/STAT [25], and mTOR signaling [2] are
thought to play a prominent role in conditioning-elicited cardioprotection.
Our study indicates that IPostC and MI enforce the regulation of genes involved in cardioprotective
pathways (RISK, JAK/STAT, and mTOR) in a similar manner independent of the time window and
myocardial region. This finding contradicts other reports showing postconditioning-mediated activation
of prosurvival cascades. In postconditioned male Wistar rat hearts, PI4K has a significant role in opening
the mitochondrial pore, thus providing cardioprotection [2]. The delayed protective effect of IPostC has
been shown to persist during activation of the PI3K-Akt pathway [23]. Further studies performed on
rodent animals have confirmed an association of IPostC-mediated cardioprotection with the activation
of JAK/STAT [26]. Zhang et al. demonstrated that IPostC reduces oxidative injury in rats [3]. Our results
demonstrate largely unchanged expression of genes involved in ROS metabolism and oxidative stress,
but an increase in ROS cannot be excluded. The discrepancies may be related to the particular animal
model and study protocol. Furthermore, data from recent clinical trials have not provided convincing
results of IPostC-elicited cardioprotection [6,27].
3.4. Opposite Regulation of Genes Involved in MI with/without IPostC, Demonstrating the Beneficial Effect of
IPostC in Microvascular Protection and Tissue Oedema
The number of significantly de-regulated genes between the IPostC and MI groups in infarcted
and remote areas at three hours was limited. In contrast, at three days more than 150 significantly DEGs
were detected, representing a complex transcriptional response to IPostC. Apparently, the eventual
effects in the first window of protection are not caused by transcriptional regulation, but rather by
alterations on the protein or cellular level.
Downregulation of ECM proteinases and upregulation of focal adhesion components in the
remote area of the IPostC-3d group indicated that postconditioning stimuli induce cytoskeleton-based
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signaling. Upregulation of the focal adhesion pathway has been attributed to cardioprotective
preconditioning stimuli in mice [28] and perfused hearts [29]; however, upregulation of focal
adhesion transcripts in the IPostC model has not been shown thus far. The focal adhesion pathway
regulates mechanical and functional changes in cardiac tissue inducing alterations in cellular structure,
proliferation rate, and cell migration [30], which may play a role in reducing microvascular oedema
and MVO. The spatial differences in overexpression of distinct focal adhesion pathway components
(e.g., integrins, cytoskeletal proteins in the infarcted area, and tyrosine kinases in the remote area)
suggest an interplay between the remote and infarcted zones of the myocardium. In addition,
we recently showed that a porcine model of preconditioning exhibits substantial gene expression
changes in the remote area, implying the prevention of adverse remodeling effects [14].
We show that a large cluster of genes involved in the formation of ribosomal subunits and vesicular
transport is downregulated in the remote area of the IPostC-3d group compared to upregulated
expression in the MI-3d group. A recent proteomics study in pigs demonstrated a decrease in these
protein clusters until 24 h after MI, followed by induction of the same proteins over the next few days
as a sign of gradual activation of the healing process and fibrosis [31]. Our data indicate that IPostC
delays the onset of remodeling; however, for a definite conclusion, more time-dependent investigations
will be necessary.
Our data also suggest that IPostC downregulates genes participating in the activation and
adhesion of platelets and leukocytes. This provides a functional link to the inhibition of MVO
and cellular oedema in this IPostC model [11]. MVO is associated with increased adhesion and
aggregation of platelets, neutrophils, and leukocytes to the ischaemia-affected tissues, contributing
to the microcirculatory perfusion deficit [32]. Here, we demonstrate that the genes responsible for
the activation of inflammatory leukocytes were significantly downregulated in the remote area of the
IPostC-3d group, suggesting that attenuated MVO by IPostC is mediated by transcriptional changes.
The more profound impact on endothelial gene regulation in the infarcted area by IPostC at three
days, both in terms of the number of altered transcripts (Figure 2) and functional clustering (Figure 6),
indicates a significant contribution of the microvasculature. An overall induction of transcripts for
DNA replication and processing, regulation of transcription, and cell division and adhesion may
explain the molecular mechanism of IPostC-mediated microvascular protection.
Two clinical studies have observed that the IPostC intervention procedure has the capacity to
increase coronary blood flow [33] and inhibit endothelial injury [34] in AMI patients. These findings
point towards a potent inhibitory effect of IPostC on microcirculatory disturbances.
3.5. Limitations
Baseline cTnI3 and myoglobin measurements to determine the enzymatic infarct size for the
individual treatment groups were not assessed, assuming normal values at baseline in the animals.
Even a preconditioning stimulus with three cycles of 10 min ischaemic/reperfusion did not result in
elevation of cTnI3 and myoglobin in our previous experiments [16].
Analysis of the transcriptome provided a comprehensive comparison of time-dependent and
regional changes in the expression of genes between the MI and IPostC groups; however, the sample
size was limited and included three biological replicates each in the MI, IPostC, and sham-operated
control groups.
Myocardial tissue consists of heterogeneous cells, mostly cardiomyocytes, endothelial cells,
and fibroblasts. In order to avoid the transcriptomic analysis of minor cells (e.g., neurons), we selected
transcripts typical for cardiac cells by bioinformatic enrichment. This selection avoids overestimation
of genetic profiles of cells that are presumably playing a marginal role in heart conditioning.
The myocardial tissue used in transcriptomic analysis represents heterogeneous starting material,
and thus, the results do not provide insight into individual gene expression changes on distinct
cellular levels.
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Inclusion of an additional three days follow-up for a sham-operated control group would promote
a more corrected comparison between the three days follow-up conditioning and sham groups.
However, we expect constant gene expression in the animals without MI, with the same anaesthetic
protocol, before tissue harvesting of the sham animals. Using the above-described study design,
we have reduced the number of sham animals, which was requested by the animal ethics committee.
The efficacy of cardioprotection by IPostC was assessed only at two time-points, therefore we cannot
rule out any beneficial or adverse effects on the later outcomes.
Isoflurane was applied in all groups and like other anaesthetics, may confer cardioprotection [35],
and thus may complicate the identification of IPostC effects. This may explain why no reduction in
infarct size was detected, but we aimed to adhere to a protocol with high relevance to clinical settings.
4. Materials and Methods
4.1. Study Design
Large animal experiments were conducted in accordance with the Guide for the Care and
Use of Laboratory Animals published by the US National Institutes of Health (NIH publication
No. 85-23, revised 2011), and were approved by the Ethics Committee of the Hungarian National Food
Chain Safety Office (Approval number: SOI/31/26-11/2014). Experiments and results were reported
according to the ARRIVE guidelines [36]. The study design is shown in Figure 1A. The detailed
experimental protocol has been published previously [11].
Briefly, female domestic pigs (n = 20, 25–30 kg) were sedated by subcutaneous administration
of 12 mg/kg ketamine hydrochloride, 1 mg/kg xylazine, and 0.04 mg/kg atropine after overnight
fasting. Following endotracheal intubation, the anaesthesia was deepened with 1.5–2.5 vol % isoflurane,
1.6–1.8 vol % O2, and 0.5 vol % N2O. A 6F introduction sheath (Terumo Medical Corporation, Somerset,
NJ, USA) was inserted into the right femoral artery. Following administration of 200 IU/kg of heparin,
6F right coronary guiding catheters were introduced into the left and right coronary ostium to perform
selective angiography of the left and right coronary arteries.
To induce MI, the LAD, after the second diagonal branch, was occluded by the inflation
of a coronary angioplasty balloon (2.75 mm diameter, 15 mm length; Maverick, Boston Natick,
MA, USA) at 5 atm for 90 min. Control angiography was performed to confirm occlusion of the
artery. Intracoronary injection of 5000 IU heparin was administered after occlusion, and immediately
before reperfusion, to avoid clot formation at the occlusion site. Reperfusion was initiated via balloon
deflation. The pigs were randomized to IPostC (n = 8) or non-conditioned MI (n = 8) groups, while
four animals underwent sham operations (Control, n = 4). Animals in the IPostC and MI groups
were further randomized to a follow-up of either three hours (IPostC-3h group, n = 4; MI-3h group,
n = 4) or three days (IPostC-3d group, n = 4; MI-3d group, n = 4; Figure 1A). Postconditioning was
elicited by six cycles of 30 s occlusion/reperfusion of the LAD. Selective coronary angiography of the
left coronary artery was performed immediately after re-opening the LAD to confirm reperfusion,
and also immediately after each postconditioning I/R cycle. At the pre-defined follow-up, animals
were humanely euthanized under general anaesthesia induced by subcutaneous injection of 12 mg/kg
ketamine hydrochloride, 1 mg/kg xylazine, and 0.04 mg/kg atropine with an intravenous injection of
10% potassium chloride solution.
Blood and tissue samples were collected at indicated time points and subjected to downstream
analysis. The explanted hearts were placed in ice-cold saline, and small parts (approx. 1 cm3) of the
distal anterior infarcted area (below the origin of the second diagonal branch, appearing as macroscopic
haemorrhagia with oedema at three hours or pale-grey color at three days) and the remote, visually
normal posterior wall were collected. TTC staining of the remaining myocardium confirmed the correct
sampling locations [11].
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4.2. ELISA
The expression of cardiac enzymes was assessed by commercially available ELISA kits, according
to the manufacturer´s instructions. Myoglobin (Porcine Myoglobin ELISA kit, USCN, Wuhan, China)
was measured from plasma samples collected at the three hours follow-up. The serum level of cTnI3
(Porcine cTnI3 ELISA kit, USCN, Wuhan, China) was assessed at the three days follow-up.
The concentrations of circulating cardioprotective markers were assessed according to the
manufacturer’s protocols. The concentrations of stromal-derived factor 1-alpha (SDF-1α; Porcine
SDF-1α ELISA kit, Neoscientific, Langenfeld, Germany), chemokine C-X-C motif receptor 4 (CXCR4;
Pig CXCR4 ELISA kit, Abbexa, Cambridge, UK), interleukin-8 (IL-8, Pig IL-8 ELISA kit, Abcam,
Cambridge, UK), matrix metalloproteinase 2 (72 kDa MMP-2, Pig MMP-2 ELISA kit, MyBiosource,
San Diego, CA, USA), fibroblast growth factor (FGF, pig FGF ELISA kit, Neoscientific, Langenfeld,
Germany), and vascular endothelial growth factor (VEGF, pig VEGF ELISA kit, Neoscientific,
Langenfeld, Germany) were determined by spectrophotometric readouts on a VICTOR3 plate reader
(Perkin Elmer, Waltham, MA, USA).
4.3. RNA Extraction
Tissues from the non-infarcted (remote zone, e.g., from the posterior myocardial region)
and infarcted areas of the left ventricle were collected from explanted hearts, washed with PBS
(Sigma-Aldrich, St. Louis, MO, USA), cut into pieces, immediately transferred into cryotubes containing
1.2 mL RNAlater® (Ambion, Austin, TX, USA), and stored at −80 ◦C. Tissue slices (~30 mg)
were homogenized using Precellys lysing kit CK28 beads (VWR, Vienna, Austria) in Qiazol lysis
buffer (Qiagen, Hilden, Germany). Total RNA was isolated using the RNeasy Microarray®Tissue kit
(Qiagen, Hilden, Germany).
4.4. RNA Sequencing
The total RNA fractions of the myocardial samples were subjected to mRNA deep sequencing
using the Illumina (San Diego, CA, USA) platform. The NEBNext Poly(A) mRNA Magnetic Isolation
Module (New England Biolabs, Ipswich, MA, USA) was utilized for mRNA fragmentation and
enrichment. Fragmented and primed mRNA was reverse transcribed to cDNA. The cDNA library
was synthesized and enriched using the NEBNext Ultra Directional RNA Library Kit (New England
Biolabs, Ipswich, MA, USA). Sequencing was performed on the HiSeq 2500 platform to a mean depth
of 15–20 million paired-end reads per sample at the Core Facility of the Medical University of Vienna.
4.5. Quantitative PCR (qPCR) Analysis for Validation of Pre-Selected Genes
mRNA (1 µg) was isolated from myocardial probes, followed by reverse transcription to cDNA
using the QuantiTect®Reverse Transcription kit (Qiagen, Hilden, Germany). Target gene expression
was assessed by qPCR on an Applied Biosystems 7500 Real-Time PCR System (Life Technologies,
Thermo Fisher Scientific, Waltham, MA, USA) using a QuantiTect SYBR Green Reaction kit (Qiagen,
Hilden, Germany), according to the manufacturer´s instructions, in biological and technical replicates.
Genes of interest were selected based on significantly differential expression in the RNA-seq analysis,
and their involvement in the focal adhesion pathway. The primers (Supplementary Table S1) for
the targeted porcine cDNAs were designed using Primer3 software and purchased from Microsynth
(Balgach, Switzerland).
Target gene expression rates were normalized to the geometric means of three reference genes:
ACTB, HPRT1, and PPIA. The relative gene expression was calculated using the ∆∆Ct method.
Expression changes were calculated relative to myocardial expression levels in the control animals.
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4.6. Statistical Analysis
Continuous parameters were compared using one-way ANOVA with multiple comparisons for
the mean at each time point using Tukey HSD post-hoc tests (R software, R Foundation for Statistical
Computing, Vienna, Austria). Details of the biostatistical analyses are described in the Supplementary
Methods. Gene expression in the ischaemic and remote myocardium of the MI and IPostC groups
at three hours and three days was compared to expression in the non-ischaemic myocardium of the
control group. The concentrations calculated from absorbance measurements in ELISA experiments
were obtained by applying a four-parameter logistic curve to the standard measurements. p < 0.05 was
considered significant.
5. Conclusions
In summary, the present study is a comprehensive analysis of IPostC, taking into account the
capacity to induce microvascular protection by reducing obstruction and oedema, and to show
whole transcriptome changes. We identified relevant transcriptional changes in genes with opposite
regulation in the MI and IPostC groups, which are involved in the activation of focal adhesion,
translational processes, and blood cells that may have critical consequences in response to I/R injury,
even if these transcriptomic changes do not translate into clinically relevant infarct size reduction at
the assessed time points.
Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/20/2/
344/s1.
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Abbreviations
DEG differentially expressed gene
ECM extracellular matrix
I/R ischaemia/reperfusion
IPostC ischaemic postconditioning
LAD left anterior descending artery
MI myocardial infarction
MRI magnetic resonance imaging
MVO microvascular obstruction
PCA principal component analysis
SPIA signaling pathway impact analysis
STEMI ST-segment elevation myocardial infarction
TTC triphenyl tetrazolium chloride
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